Warning: The NCBI web site requires JavaScript to function. more...
Pulmonary hypertension associated with sarcoidosis.
Baughman RP.
Arthritis Res Ther. 2007;9 Suppl 2:S8. Review.
Related citations
Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists?
Pitsiou GG, Spyratos D, Kioumis I, Boutou AK, Nakou C, Stanopoulos I.
Ther Adv Respir Dis. 2009 Jun;3(3):99-101. Epub 2009 Jul 28.
Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.
Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman JS, Farber HW.
Chest. 2006 Nov;130(5):1481-8.
Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan.
Foley RJ, Metersky ML.
Respiration. 2008;75(2):211-4. Epub 2005 Nov 15.
Sarcoidosis-associated pulmonary hypertension: assessment and management.
Palmero V, Sulica R.
Semin Respir Crit Care Med. 2010 Aug;31(4):494-500. Epub 2010 Jul 27. Review.
Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis.
Handa T, Nagai S, Miki S, Fushimi Y, Ohta K, Mishima M, Izumi T.
Chest. 2006 May;129(5):1246-52.
[Pulmonary hypertension in COPD and interstitial lung diseases].
Markart P, Ghofrani HA, Grimminger F, Günther A.
Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S164-6. Epub 2009 Aug 28. Review. German.
Pulmonary hypertension and granulomatous vasculitis in sarcoidosis.
Shigemitsu H, Nagai S, Sharma OP.
Curr Opin Pulm Med. 2007 Sep;13(5):434-8. Review.
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis.
Nunes H, Humbert M, Capron F, Brauner M, Sitbon O, Battesti JP, Simonneau G, Valeyre D.
Thorax. 2006 Jan;61(1):68-74. Epub 2005 Oct 14.
Clinical predictors of pulmonary hypertension in sarcoidosis.
Bourbonnais JM, Samavati L.
Eur Respir J. 2008 Aug;32(2):296-302. Epub 2008 Apr 2.
Pulmonary hypertension in sarcoidosis: a review.
Corte TJ, Wells AU, Nicholson AG, Hansell DM, Wort SJ.
Respirology. 2011 Jan;16(1):69-77. doi: 10.1111/j.1440-1843.2010.01872.x. Review.
Pulmonary hypertension complicating sarcoidosis.
Rhodes B, Chambers D, Musk M, Gabbay E.
Intern Med J. 2008 Jul;38(7):613-4; author reply 614. No abstract available.
["Sarcoidosis-like" granulomatous disease in patients with common variable hypogammaglobulinemia].
Matucci A, Rossi O, Cecchi L, Vultaggio A, Checcacci S, Parronchi P, Emmi L, Maggi E, Romagnani S.
Ann Ital Med Int. 2002 Apr-Jun;17(2):108-16. Italian.
Pulmonary hypertension in sarcoidosis.
Baughman RP, Engel PJ, Meyer CA, Barrett AB, Lower EE.
Sarcoidosis Vasc Diffuse Lung Dis. 2006 Jun;23(2):108-16.
Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension.
Sulica R, Teirstein AS, Kakarla S, Nemani N, Behnegar A, Padilla ML.
Chest. 2005 Sep;128(3):1483-9.
Interstitial lung disease: trials and tribulations.
Afshar K, Sharma OP.
Curr Opin Pulm Med. 2008 Sep;14(5):427-33. Review.
[Respiratory mechanics in patients with stage III pulmonary sarcoidosis and idiopathic fibrosing alveolitis: similarities and differences].
Bogorodskaia EM, Evfim'evskiĭ VO, Borisov SE.
Probl Tuberk Bolezn Legk. 2006;(4):41-5. Russian.
Increased endothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis.
Terashita K, Kato S, Sata M, Inoue S, Nakamura H, Tomoike H.
Respirology. 2006 Mar;11(2):145-51.
Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics.
Shorr AF, Helman DL, Davies DB, Nathan SD.
Eur Respir J. 2005 May;25(5):783-8.
Sickle cell disease, pulmonary hypertension, and sarcoidosis.
Lehmann LH, Riess H, Sturm I.
Ann Hematol. 2008 Jul;87(7):591-2. Epub 2008 Jan 29. No abstract available.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on